[Experimental evaluation of the use of recombinant prourokinase and its immobilized forms in the treatment of postoperative fibrinoid syndrome in ophthalmology].
Boĭko
E V
EV
Danilichev
V F
VF
Kol'tsova
S V
SV
D000818:Animals; D004800:Enzymes, Immobilized; D005337:Fibrin; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014821:Vitrectomy / Q000009:adverse effects*; D014822:Vitreous Body / Q000187:drug effects / Q000473:pathology*
D004800:Enzymes, Immobilized; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D005337:Fibrin; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase